Novel pathologic findings in patients with Pelizaeus-Merzbacher disease

Jeremy J Laukka1, John Kamholz2, Denise Bessert3

  • 1Department of Neuroscience, University of Toledo, College of Medicine and Life Science, Toledo, OH 43614, United States; Department of Neurology, University of Toledo, College of Medicine and Life Science, Toledo, OH 43614, United States.

Insights

Pelizaeus-Merzbacher disease (PMD) involves myelin defects in the central nervous system (CNS). This study reveals distinct microscopic pathologies in PMD patients with PLP1 deletions versus duplications, indicating heterogeneous disease mechanisms.

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Background:

  • Pelizaeus-Merzbacher disease (PMD) is an X-linked hypomyelinating disorder.
  • Mutations in the proteolipid protein 1 (PLP1) gene cause PMD.
  • The precise nature of hypomyelination in PMD was previously unclear.

Purpose of the Study:

  • To compare the microscopic myelin pathology in PMD patients with PLP1 deletions versus duplications.
  • To elucidate the distinct mechanisms underlying myelin defects in different PMD genotypes.

Main Methods:

  • Autopsy brain tissue from PMD patients (3 with PLP1 duplications, 1 with PLP1 deletion) was analyzed.
  • Techniques included paraffin embedding for immunocytochemistry and plastic embedding for electron microscopy.
  • High-resolution fiber pathology of the cerebrum and corpus callosum was examined.

Main Results:

  • PLP1 deletion: Myelin sheath splitting and decompaction observed, similar to rodent models. Abnormally thin myelin and axonal degeneration were noted.
  • PLP1 duplication: Swellings, constriction, involution of myelin, segmental demyelination, and abnormally thick myelin sheaths were characteristic.
  • Common findings included myelin involution, myelin balls, and axonal degeneration.

Conclusions:

  • Distinct microscopic pathologies correlate with specific PLP1 mutation types (deletion vs. duplication) in PMD.
  • These findings suggest heterogeneous mechanisms driving fiber pathology in PMD.
  • Oligodendrocyte dysfunction and attempted myelination contribute to the observed pathologies.